首页> 外文OA文献 >Osimertinib (AZD9291) Enhanced the Efficacy of Chemotherapeutic Agents in ABCB1- and ABCG2-Overexpressing Cells In Vitro, In Vivo, and Ex Vivo

【2h】

Osimertinib (AZD9291) Enhanced the Efficacy of Chemotherapeutic Agents in ABCB1- and ABCG2-Overexpressing Cells In Vitro, In Vivo, and Ex Vivo

机译：Osimertinib（AZD9291）增强了化学治疗剂在体外，体内和离体中的化学治疗剂在ABCB1和ABCG2过表达细胞中的疗效

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Zhen Chen; Yifan Chen; Meng Xu; Likun Chen; Xu Zhang; Kenneth Kin Wah To; Hongyun Zhao; Fang Wang; Zhongjun Xia; Xiaoqin Chen; Liwu Fu;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Osimertinib (AZD9291) Enhanced the Efficacy of Chemotherapeutic Agents in ABCB1-and ABCG2-Overexpressing Cells In Vitro, In Vivo, and Ex Vivo [J] . Chen Zhen, Chen Yifan, Xu Meng, Molecular cancer therapeutics . 2016,第8期

机译：奥西替尼（AZD9291）增强了ABCB1和ABCG2过表达细胞中体外，体内和体外化学治疗剂的功效
2. Rociletinib (CO-1686) enhanced the efficacy of chemotherapeutic agents in ABCG2-overexpressing cancer cells in?vitro and in vivo [J] . Fanpu Zeng, Fang Wang, Zongheng Zheng, Acta Pharmaceutica Sinica B . 2020,第5期

机译：Rociletinib（CO-1686）增强了化学治疗剂在体外和体内ABCG2过表达癌细胞中的化学治疗剂的疗效
3. Rociletinib(CO-1686) enhanced the efficacy of chemotherapeutic agents in ABCG2-overexpressing cancer cells in vitro and in vivo [J] . Fanpu Zeng, Fang Wang, Zongheng Zheng, 药学学报：英文版 . 2020,第005期

机译：Rociletinib（CO-1686）在体外和体内增强过表达ABCG2癌细胞中化疗药物的功效
4. ACTIVITY OF LIPOSOMAL CLODRONATE AGAINST CANINE MALIGNANT HISTIOCYCTIC CELLS IN VITRO AND PRELIMINARY EVIDENCE OF IN VIVO EFFICACY IN DOGS WITH MALIGNANT HISTIOCYTOSIS [C] . Scott Hafeman, Ryan Troyer, Steven Dow Annual Conference of the Veterinary Cancer Society . 2009

机译：对犬恶性肿瘤细胞的脂质体Clodronate的活性在体外和初步证据表明恶性组织细胞症的体内疗效
5. Landscape Phage Fusion Protein-Modified Pharmaceutical Nanocarriers for Targeted and Cytoplasmic Delivery of Chemotherapeutics to Breast Cancer Cells in Vitro and in Vivo. [D] . Wang, Tao. 2012

机译：景观噬菌体融合蛋白修饰的药物纳米载体，可在体内和体外将化学治疗药物靶向性和细胞质地递送至乳腺癌细胞。
6. Rociletinib (CO-1686) enhanced the efficacy of chemotherapeutic agents in ABCG2-overexpressing cancer cells in vitro and in vivo [O] . Fanpu Zeng, Fang Wang, Zongheng Zheng, 2020

机译：Rociletinib（CO-1686）在体外和体内增强过表达ABCG2癌细胞中化疗药物的功效
7. MK-2206, an Allosteric Akt Inhibitor, Enhances Antitumor Efficacy by Standard Chemotherapeutic Agents or Molecular Targeted Drugs In vitro and In vivo [O] . Hiroshi Hirai, Hiroshi Sootome, Yoko Nakatsuru, 2010

机译：MK-2206，一个颠覆性Akt抑制剂，通过标准化学治疗剂或体外和体内分子靶向药物增强抗肿瘤效果
8. SURVIVAL OF CLONOGENIC CELLS FROM A MURINE SOLID TUMOR TREATED IN VIVO WITH RADIATION AND CHEMOTHERAPEUTIC AGENTS [R] . Moody D. Wharam, Theodore L. Phillips, Lawrence Kane 1973

机译：用放射和化学治疗剂治疗体内治疗的小鼠固体瘤的克隆细胞存活率

Osimertinib (AZD9291) Enhanced the Efficacy of Chemotherapeutic Agents in ABCB1- and ABCG2-Overexpressing Cells In Vitro, In Vivo, and Ex Vivo

著录项

引文网络

相似文献

相关主题

期刊订阅